To further define the surface of the Torpedo californica nicotinic acetylcholine receptor (nAChR) contributing to the agonist binding site structure, we used the substituted Cys accessibility method to identify novel residues and determined the "footprint" of residues protected from modification by the reversible competitive antagonist d-tubocurarine (dTC). nAChRs containing single Cys substitutions within regions of the ␣-or ␥-subunit primary structure known to contribute to the agonist binding site were expressed in Xenopus laevis oocytes. Cys substitutions in binding site segments A (␣Tyr-93 and ␣Asn-94), C (␣Tyr-198), and D (␥Glu-57) had been shown previously to be accessible for modification. We now introduced cysteines from ␣Asp-195 to ␣Ile-201 and from ␥Ala-106 to ␥Asp-113 and identified positions accessible for modification in segments C ) and E (␥Asn-107 and ␥Leu-109). dTC protected against alkylation in segments D (␥Glu-57) and E (␥Leu-109) but not in segment A (␣Tyr-93 and ␣Asn-94). In segment C, dTC protection experiments revealed a pattern in which every other residue (␣196, ␣198, and ␣200, but not ␣197 or ␣201) was protected from alkylation. This pattern of protection provides evidence that bound dTC is near amino acids in segments C, D, and E but not in segment A, and identifies a -strand surface within segment C contributing to the binding site. These results are discussed in terms of a homology model, based on the molluscan acetylcholine binding protein crystal structure, of the T. californica nAChR agonist binding site.